Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey-Reference-Cited by-同舟云学术

Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey

Published:2023-10 Issue: Volume:190 Page:104103
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Fusco Nicola^ORCID,Ivanova Mariia,Frascarelli Chiara,Criscitiello Carmen,Cerbelli Bruna,Pignataro Maria Gemma,Pernazza Angelina,Sajjadi Elham,Venetis Konstantinos,Cursano Giulia,Pagni Fabio,Di Bella Camillo,Accardo Marina,Amato Michelina,Amico Paolo,Bartoli Caterina,Bogina Giuseppe,Bortesi Laura,Boldorini Renzo,Bruno Sara,Cabibi Daniela,Caruana Pietro,Dainese Emanuele,De Camilli Elisa,Dell’Anna Vladimiro,Duda Loren,Emmanuele Carmela,Fanelli Giuseppe Nicolò,Fernandes Bethania,Ferrara Gerardo,Gnetti Letizia,Gurrera Alessandra,Leone Giorgia,Lucci Raffaella,Mancini Cristina,Marangi Grazia,Mastropasqua Mauro G.,Nibid Lorenzo,Orrù Sandra,Pastena Maria,Peresi Monica,Perracchio Letizia,Santoro Angela,Vezzosi Vania,Zambelli Claudia,Zuccalà Valeria,Rizzo Antonio,Costarelli Leopoldo,Pietribiasi Francesca,Santinelli Alfredo,Scatena Cristian,Curigliano Giuseppe,Guerini-Rocco Elena,Martini Maurizio,Graziano Paolo,Castellano Isabella,d'Amati Giulia

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference72 articles.

1. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study;Adams;Ann. Oncol.,2019

2. PD−L1 immunostaining: what pathologists need to know;Akhtar;Diagn. Pathol.,2021

3. The role of the pathologist in the next-generation era of tumor molecular characterization;Angerilli;Diagnostics,2021

4. The performance of digital microscopy for primary diagnosis in human pathology: a systematic review;Araújo;Virchows Arch.,2019

5. Digital pathology and artificial intelligence in translational medicine and clinical practice;Baxi;Mod. Pathol.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores;Human Pathology;2024-02

2. Think “HER2” different: integrative diagnostic approaches for HER2-low breast cancer;Pathologica;2023-12

3. Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer;Virchows Archiv;2023-09-28